Timothy Daley
Stock Analyst at Wells Fargo
(2.03)
# 3,071
Out of 5,008 analysts
58
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $47 | $46.80 | -0.26% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $7.53 | +165.60% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $91.19 | +4.18% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $34.56 | +108.33% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $138.56 | +4.65% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,309.12 | -0.70% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $318.35 | -10.48% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $208.77 | +18.31% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $170.10 | +61.67% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $279.62 | -3.44% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $5.59 | +400.89% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $24.06 | +45.47% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $539.17 | -3.56% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $1.39 | +547.48% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $145.93 | +26.77% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $67.73 | +25.50% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $200.86 | +9.53% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $186.65 | +17.87% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $13.47 | +107.87% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $181.89 | -23.03% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $59.19 | +52.05% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $47
Current: $46.80
Upside: -0.26%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $7.53
Upside: +165.60%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $91.19
Upside: +4.18%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $34.56
Upside: +108.33%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $138.56
Upside: +4.65%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,309.12
Upside: -0.70%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $318.35
Upside: -10.48%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $208.77
Upside: +18.31%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $170.10
Upside: +61.67%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $279.62
Upside: -3.44%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $5.59
Upside: +400.89%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $24.06
Upside: +45.47%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $539.17
Upside: -3.56%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $1.39
Upside: +547.48%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $145.93
Upside: +26.77%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $67.73
Upside: +25.50%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $200.86
Upside: +9.53%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $186.65
Upside: +17.87%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $13.47
Upside: +107.87%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $181.89
Upside: -23.03%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $59.19
Upside: +52.05%